When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OPTN - OptiNose out-licenses Onzetra Xsail to Currax Pharma
OptiNose Inc.
OptiNose's (NASDAQ:OPTN) Norway-based subsidiary OptiNose AS has signed an agreement with Currax Pharmaceuticals granting the latter exclusive rights to certain of its intellectual property for the purpose of marketing Onzetra Xsail (sumatriptan nasal powder) in U.S., Canada, and Mexico.
More news on: OptiNose, Inc., Healthcare stocks news,